Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
novel transcript, antisense to GNAI2
- Molecular classification
- Other (long non-coding RNA, natural antisense transcript)
01
Overview
A natural antisense transcript (NAT) to GNAI2 is a long non-coding RNA molecule transcribed from the DNA strand opposite to the GNAI2 gene locus. Such antisense transcripts are increasingly recognized for their regulatory roles, typically influencing the expression, stability, or translation of their corresponding sense partner genes, here GNAI2. Mechanistically, antisense lncRNAs may act by sponging microRNAs, interfering with transcription, modulating mRNA degradation, recruiting chromatin modifiers, or altering local chromatin structure. However, this particular transcript (ENSG00000302205) does not encode a protein, has not been established as a direct therapeutic target, and lacks reported drug interactions or established disease biomarker roles.
- Other names
- antisense lncRNA to GNAI2GNAI2-AS (generic)ENSG00000302205
02
Biological functions
Regulation of gene expression (post-transcriptional and potentially epigenetic regulation)modulation of mRNA stabilitypossible involvement in processes such as transcriptional interference, RNA sponging, and chromatin remodeling
03
Disease associations
Other (lncRNAs and antisense transcripts are increasingly implicated in diverse diseases, including cancer and developmental disorders, but there is no specific, established disease role for this transcript)
Beyond the preview
Go deeper on novel transcript, antisense to GNAI2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on novel transcript, antisense to GNAI2.